SCHEMBL7129686

SCHEMBL7129686

COc1ccc(C(=O)O)c2c3c(n(CC4CCCCC4)c12)CCCC3

nearest known ligand 0.45

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 9/20 0.45
CNR1 P21554 9/20 0.42
CNR2 P34972 8/20 0.42
FABP3 P05413 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7176265 0.91 CNR1 (0.43) FABP4CNR1CNR2
SCHEMBL7131196 0.83 CNR1 (0.45) CNR1CNR2
SCHEMBL7122581 0.81 PDE4B (0.53)
SCHEMBL7066692 0.80 FABP4 (0.60) FABP4FABP3
SCHEMBL5022760 0.76 CNR1 (0.44) CNR1CNR2
SCHEMBL7122377 0.70 FABP4 (0.51) FABP4FABP3
SCHEMBL3424668 0.69 MAPT (0.50) FABP4
SCHEMBL5022790 0.67 CNR1 (0.44) CNR1CNR2
SCHEMBL3567919 0.67 CNR1 (0.70) CNR1CNR2
SCHEMBL8327219 0.66 GFER (0.49) FABP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004069831-A1 TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS LTD. (US) 2004-08-19 WO disclosed
WO-2004069831-A1 TRICYCLIC COMPOUNDS USEFUL FOR THE TREATMENT OF INFLAMMATORY AND ALLERGIC DISORDERS: PROCESS FOR THEIR PREPARATION GLENMARK PHARMACEUTICALS LTD. (US) 2004-08-19 WO disclosed